Patients experiencing persistent vomiting or diarrhea should be monitored for signs of dehydration and renal dysfunction, with appropriate fluid replacement and potentially temporary discontinuation of the medication if necessary
Safdar explained, that a pharmacist may need to make a medication that is in shortage or might need to somehow modify the "official" version of the drug
As a novel multi-agonist peptide, it acts on GLP-1, GIP, and glucagon receptors, three key pathways involved in appetite regulation, glucose metabolism, and fat utilization
For patients navigating new therapies, this means having a trusted source to explain the benefits, risks, and practical considerations of these medications
PlexusDx provides personalized semaglutide treatment through licensed 503A compounding pharmacies, allowing patients to understand their unique metabolic response timeline based on individual factors
Concentration and mental clarity